Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
Italian Journal of Pediatrics|August 24, 2019
Comprehensive approach to weaning in difficult-to-wean infantile and juvenile-onset glycogen-storage disease type II patients: a case seriesLingling Xu, Hongjun Ba, Yuxin Pei, et al.Journal of Clinical Immunology|May 9, 2026
Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3Yuxin Pei, Bei Jin, Reyila Abasi, et al.International Journal of Nanomedicine|December 30, 2020
A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination ChemotherapyChenxi Hou, Ning Ma, Ziyan Shen, et al.Chemical Communications (Cambridge, England)|August 1, 2024
A nanoplatform based on allylthiopurine bio-MOF and glycosylated AIE PARP inhibitor for cancer synthetic lethal therapyBingling Gao, Ke Yang, Manman Yang, et al.Chemical Communications (Cambridge, England)|September 15, 2022
A supramolecular nano-delivery system based on AIE PARP inhibitor prodrug and glycosylated pillar[5]arene for drug-resistance therapyManman Yang, Ke Yang, Bingling Gao, et al.International Journal of Nanomedicine|April 27, 2018
Dual-responsive dithio-polydopamine coated porous CeO2 nanorods for targeted and synergistic drug deliveryYing Zhang, Xiaowen Wu, Chenxi Hou, et al.Renal Failure|February 21, 2024
Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndromeNannan Yu, XiaoJun Ouyang, Jie Li, et al.Analytical Chemistry|August 21, 2007
Photoderivatized polymer thin films at quartz crystal microbalance surfaces: sensors for carbohydrate-protein interactionsYuxin Pei, Hui Yu, Zhichao Pei, et al.ACS Applied Materials & Interfaces|April 28, 2022
Nanococktail Based on Supramolecular Glyco-Assembly for Eradicating Tumors In VivoWeiwei Feng, Shangqian Zhang, Yichen Wan, et al.Journal of Nanobiotechnology|February 19, 2025
Remodeling tumor microenvironment using prodrug nMOFs for synergistic cancer therapyJunliang Dong, Jindong Ding, Shifan Luo, et al.Pageof 12